Literature DB >> 8316057

Garlic supplementation and lipoprotein oxidation susceptibility.

S Phelps1, W S Harris.   

Abstract

Interventions which make serum lipoproteins less susceptible to oxidation may be antiatherogenic. The antioxidant properties of garlic which have been demonstrated in vitro led us to investigate the effects of garlic supplements on lipoprotein oxidation susceptibility in humans. Ten healthy volunteers were given 600 mg/d of garlic powder (6 tablets of Kwai) for two weeks in a placebo-controlled, randomized, double-blind crossover trial. We found that although serum lipid and lipoprotein levels were not lowered in this short time period, the ex vivo susceptibility of apolipoprotein B-containing lipoproteins to oxidation was significantly decreased (-34%). Because garlic has been reported to beneficially affect serum lipid levels, platelet function, fibrinolysis and blood pressure, this additional effect of retarding lipoprotein oxidation may contribute to the potential antiatherosclerotic effect of garlic.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8316057     DOI: 10.1007/bf02535949

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  14 in total

1.  Effect of garlic on thrombocyte aggregation, microcirculation, and other risk factors.

Authors:  H Kiesewetter; F Jung; G Pindur; E M Jung; C Mrowietz; E Wenzel
Journal:  Int J Clin Pharmacol Ther Toxicol       Date:  1991-04

Review 2.  Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity.

Authors:  D Steinberg; S Parthasarathy; T E Carew; J C Khoo; J L Witztum
Journal:  N Engl J Med       Date:  1989-04-06       Impact factor: 91.245

3.  Effect on active oxygen species of alliin and Allium sativum (garlic) powder.

Authors:  P N Kourounakis; E A Rekka
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1991-11

4.  Effect of dried garlic on blood coagulation, fibrinolysis, platelet aggregation and serum cholesterol levels in patients with hyperlipoproteinemia.

Authors:  J Harenberg; C Giese; R Zimmermann
Journal:  Atherosclerosis       Date:  1988-12       Impact factor: 5.162

5.  Precipitation methods for quantification of lipoproteins.

Authors:  P S Bachorik; J J Albers
Journal:  Methods Enzymol       Date:  1986       Impact factor: 1.600

6.  Inhibition of platelet aggregation and thromboxane synthesis by onion and garlic.

Authors:  A N Makheia; J Y Vanderhoek; J M Bailey
Journal:  Lancet       Date:  1979-04-07       Impact factor: 79.321

7.  Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit.

Authors:  T E Carew; D C Schwenke; D Steinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

8.  Low density lipoprotein rich in oleic acid is protected against oxidative modification: implications for dietary prevention of atherosclerosis.

Authors:  S Parthasarathy; J C Khoo; E Miller; J Barnett; J L Witztum; D Steinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

9.  Effects of a low saturated fat, low cholesterol fish oil supplement in hypertriglyceridemic patients. A placebo-controlled trial.

Authors:  W S Harris; C A Dujovne; M Zucker; B Johnson
Journal:  Ann Intern Med       Date:  1988-09-15       Impact factor: 25.391

10.  Physiologic levels of ascorbate inhibit the oxidative modification of low density lipoprotein.

Authors:  I Jialal; G L Vega; S M Grundy
Journal:  Atherosclerosis       Date:  1990-06       Impact factor: 5.162

View more
  16 in total

1.  Comparative study of hypocholesterolemic and hypolipidemic effects of conjugated linolenic acid isomers against induced biochemical perturbations and aberration in erythrocyte membrane fluidity.

Authors:  Siddhartha S Saha; Anirban Chakraborty; Santinath Ghosh; Mahua Ghosh
Journal:  Eur J Nutr       Date:  2011-08-04       Impact factor: 5.614

2.  Antioxidant activity of amiodarone on human lipoprotein oxidation.

Authors:  D Lapenna; G Ciofani; C Bruno; S D Pierdomenico; F Cuccurullo
Journal:  Br J Pharmacol       Date:  2001-07       Impact factor: 8.739

3.  Dietary effects of conjugated octadecatrienoic fatty acid (9 cis, 11 trans, 13 trans) levels on blood lipids and nonenzymatic in vitro lipid peroxidation in rats.

Authors:  P Dhar; S Ghosh; D K Bhattacharyya
Journal:  Lipids       Date:  1999-02       Impact factor: 1.880

4.  Protective effects of Allium sativum against defects of hypercholesterolemia on pregnant rats and their offspring.

Authors:  Hassan I El-Sayyad; Amoura M Abou-El-Naga; Abdelalim A Gadallah; Iman H Bakr
Journal:  Int J Clin Exp Med       Date:  2010-06-10

5.  Inhibition of human low density lipoprotein oxidation by active principles from spices.

Authors:  K Akhilender Naidu; N B Thippeswamy
Journal:  Mol Cell Biochem       Date:  2002-01       Impact factor: 3.396

6.  Effect of garlic supplementation on oxidized low density lipoproteins and lipid peroxidation in patients of essential hypertension.

Authors:  Veena Dhawan; Sanjay Jain
Journal:  Mol Cell Biochem       Date:  2004-11       Impact factor: 3.396

7.  Protective action on human LDL against oxidation and glycation by four organosulfur compounds derived from garlic.

Authors:  Chu-Chyn Ou; Shyh-Ming Tsao; Ming-Cheng Lin; Mei-Chin Yin
Journal:  Lipids       Date:  2003-03       Impact factor: 1.880

8.  Self-care: An Australian case study of chiropractic patients.

Authors:  Jennifer R Jamison
Journal:  J Chiropr Med       Date:  2002

9.  Dietary comparison of conjugated linolenic acid (9 cis, 11 trans, 13 trans) and alpha-tocopherol effects on blood lipids and lipid peroxidation in alloxan-induced diabetes mellitus in rats.

Authors:  P Dhar; D Bhattacharyya; D K Bhattacharyya; S Ghosh
Journal:  Lipids       Date:  2006-01       Impact factor: 1.880

10.  Cholesterol-lowering effect of allicin on hypercholesterolemic ICR mice.

Authors:  Yin Lu; Zhuojin He; Xiuying Shen; Xiaolu Xu; Jie Fan; Shaohua Wu; Deyong Zhang
Journal:  Oxid Med Cell Longev       Date:  2012-08-09       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.